⌘K

Login Start Free

Home/Filings/4/0000950170-24-033845

4//SEC Filing

Tada Hiroomi 4

Accession 0000950170-24-033845

CIK 0001863127other

View on SEC.gov Company Profile

Filed

Mar 18, 8:00 PM ET

Accepted

Mar 19, 7:58 PM ET

Size

4.5 KB

Accession

0000950170-24-033845

Insider Transaction Report

Form 4

Period: 2024-03-15

Tyra Biosciences, Inc.TYRA

Chief Medical Officer

Transactions

Award
Common Stock
2024-03-15$6.58/sh+1,968$12,947→ 86,435 total

Footnotes (1)

[F1]These shares were acquired under the Issuer's 2021 Employee Stock Purchase Plan.

Documents

1 file

4
ownership.xmlPrimary
4

Issuer

Tyra Biosciences, Inc.

CIK 0001863127

Entity typeother

Related Parties

1

filerCIK 0001880593

Filing Metadata

Form type: 4
Filed: Mar 18, 8:00 PM ET
Accepted: Mar 19, 7:58 PM ET
Size: 4.5 KB

View on SEC.gov